U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT06880718) titled 'Injectable Buprenorphine in Prison: a Preference Trial' on March 05.
Brief Summary: The goal of this pilot trial is to compare two branded extended-release buprenorphine (XR-B) formulations (Sublocade vs. Brixadi) to explore how they improve treatment retention after release from prison among incarcerated individuals with opioid use disorder (OUD) who are transitioning back into the community.
The main question it aims to answer are:
How do Sublocade and Brixadi compare in terms of feasibility, acceptability, and effectiveness? Does giving people a choice of medication affect how well they stay in treatment?
Using a partially ra...